Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mortality factor 4-like protein 2 (MORF4L2) is a nuclear protein encoded on the human X chromosome and operates as a component of the NuA4 histone acetyltransferase complex, which modulates chromatin structure and promotes transcriptional activation of select genes by mediating histone H4 and H2A acetylation[1][2][8]. These epigenetic modifications can alter nucleosome–DNA interactions and facilitate recruitment of additional proteins that regulate gene transcription. MORF4L2 is also implicated in the positive regulation of homologous recombination repair of double-strand DNA breaks and cell cycle regulation, and may contribute to complexes with both pro- and anti-transcriptional properties. Its roles intersect with those of several other chromatin regulators, and mutations or dysregulation have rare disease associations, but typically it is not a direct therapeutic or diagnostic target[1][2][8][7].
Not applicable, since no drugs are known to target MORF4L2 directly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mortality factor 4-like protein 2 (MORF4L2).